Equine SAA antibody and antigen (recombinant protein)

Diagnostic anti-Equine SAA antibodies pairs and antigen for animal health (animal Equine/Horse Acute inflammation, infections) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-Serum-amyloid-A-Ag01Equine SAA$3090.00
GMP-EQU-Serum-amyloid-A-Ab01Anti-Equine SAA mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-Serum-amyloid-A-Ab02Anti-Equine SAA mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-Serum-amyloid-A-Ab03Anti-Equine SAA human monoclonal antibody (mAb)$3090.00
GMP-EQU-Serum-amyloid-A-Ab04Anti-Equine SAA human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-Serum-amyloid-A-Ag01
Product NameEquine SAA
Target/BiomarkerEquine SAA
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine SAA antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Serum amyloid A level test of animal Equine/Horse with Acute inflammation, infections.
TagHis
Reconized/Reactive SpecicsEquine SAA
Product descriptionRecombinant Equine SAA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-Serum-amyloid-A-Ab01,GMP-EQU-Serum-amyloid-A-Ab02
Target/BiomarkerEquine SAA
Product NameAnti-Equine SAA mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine SAA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine SAA antibodies in Equine SAA level test of animal Equine/Horse with Acute inflammation, infections.
Product descriptionAnti-Equine SAA mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine SAA antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-Serum-amyloid-A-Ab03,GMP-EQU-Serum-amyloid-A-Ab04
Target/BiomarkerEquine SAA
Product NameAnti-Equine SAA human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine SAA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine SAA antibodies in Equine SAA level test of animal Equine/Horse with Acute inflammation, infections.
Product descriptionAnti-Equine SAA mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    SAA, Serum Amyloid A, is a versatile and indispensable biomarker within the context of horses (equines). This protein assumes a central role in the equine immune system's response to inflammatory challenges. Primarily synthesized by hepatocytes in the liver, SAA is swiftly released into the bloodstream in response to various inflammatory signals, including those triggered by infections, tissue damage, or other inflammatory conditions.

    Structurally, SAA comprises two primary isoforms in horses, SAA1 and SAA2, both of which can be elevated during inflammatory conditions. These isoforms play a pivotal role in modulating the host's immune response to pathogens and injuries. SAA acts as a chemoattractant for immune cells, facilitating their migration to the site of infection or inflammation. Additionally, SAA can influence other immune responses, including the production of cytokines and other inflammatory mediators.

    In horses, SAA serves as a sensitive and early marker of systemic inflammation. When exposed to inflammatory stimuli, such as infections, tissue damage, or other inflammatory conditions, the liver rapidly increases the synthesis of SAA. Elevated levels of SAA in the bloodstream can be detected within hours of the initial trigger, making it a valuable diagnostic tool for veterinarians.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.